Changes in the Transcriptome of the Human Endometrial Ishikawa Cancer Cell Line Induced by Estrogen, Progesterone, Tamoxifen, and Mifepristone (RU486) as Detected by RNA-Sequencing

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Tamm Rosenstein, Karin ^a,b,c   Simm, Jaak ^a   Suhorutshenko, Marina ^a   Salumets, Andres ^b,d   Metsis, Madis ^b,e  

^a TALLINN UNIVERSITY OF TECHNOLOGY   (Estonia)

^b Competence Centre on Reproductive Medicine and Biology ^*  (Estonia)

^c Nova Vita Clinic   (Estonia)

^d UNIVERSITY OF TARTU   (Estonia)

^e TALLINN UNIVERSITY   (Estonia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; ESTROGEN; ESTROGEN RECEPTOR; MESSENGER RNA; MIFEPRISTONE; PROGESTERONE; PROGESTERONE RECEPTOR; TAMOXIFEN;

APOPTOSIS; ARTICLE; ATP5G2 GENE; ATP5H GENE; CDH2 GENE; CELL ADHESION; CELL CONTACT; COL2A1 GENE; CONTROLLED STUDY; CTNND1 GENE; DOWN REGULATION; ENDOMETRIUM BIOPSY; ENDOMETRIUM CELL; EZH2 GENE; FEMALE; GENE EXPRESSION PROFILING; GNB2L1 GENE; GYNECOLOGIC DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IL6ST GENE; IQGAP1 GENE; JUP GENE; MDK GENE; MUC1 GENE; PSAP GENE; RNA SEQUENCE; SLIT2 GENE; TRANSCRIPTOMICS; UPREGULATION;

CELL LINE, TUMOR; ENDOMETRIAL NEOPLASMS; ESTROGENS; FEMALE; GENE EXPRESSION PROFILING; GTP-BINDING PROTEINS; HUMANS; MEMBRANE PROTEINS; MIFEPRISTONE; MITOCHONDRIAL PROTEINS; NEOPLASM PROTEINS; PROGESTERONE; RECEPTORS, CELL SURFACE; TAMOXIFEN; TRANSCRIPTOME;

EID: 84880498103     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068907     Document Type: Article

References (67)

1. Graham JD, Clarke CL, (1997) Physiological action of progesterone in target tissues. Endocr Rev 18: 502-519.
2. Carson DD, Lagow E, Thathiah A, Al-Shami R, Farach-Carson MC, et al. (2002) Changes in gene expression during the early to mid-luteal (receptive phase) transition in human endometrium detected by high-density microarray screening. Mol Hum Reprod 8: 871-879.
3. Kao LC, Tulac S, Lobo S, Imani B, Yang JP, et al. (2002) Global gene profiling in human endometrium during the window of implantation. Endocrinology 143: 2119-2138.
4. Borthwick JM, Charnock-Jones DS, Tom BD, Hull ML, Teirney R, et al. (2003) Determination of the transcript profile of human endometrium. Mol Hum Reprod 9: 19-33.
5. Riesewijk A, Martin J, van Os R, Horcajadas JA, Polman J, et al. (2003) Gene expression profiling of human endometrial receptivity on days LH+2 versus LH+7 by microarray technology. Mol Hum Reprod 9: 253-264.
6. Horcajadas JA, Riesewijk A, Martin J, Cervero A, Mosselman S, et al. (2004) Global gene expression profiling of human endometrial receptivity. J Reprod Immunol 63: 41-49.
7. Mirkin S, Nikas G, Hsiu JG, Diaz J, Oehninger S, (2004) Gene expression profiles and structural/functional features of the peri-implantation endometrium in natural and gonadotropin-stimulated cycles. J Clin Endocrinol Metab 89: 5742-5752.
8. Talbi S, Hamilton AE, Vo KC, Tulac S, Overgaard MT, et al. (2006) Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women. Endocrinology 147: 1097-1121.
9. Altmae S, Martinez-Conejero JA, Salumets A, Simon C, Horcajadas JA, et al. (2010) Endometrial gene expression analysis at the time of embryo implantation in women with unexplained infertility. Mol Hum Reprod 16: 178-187.
10. Haouzi D, Assou S, Mahmoud K, Tondeur S, Reme T, et al. (2009) Gene expression profile of human endometrial receptivity: comparison between natural and stimulated cycles for the same patients. Hum Reprod 24: 1436-1445.
11. Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, et al. (1997) Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab 82: 4258-4265.
12. Kuiper GG, Gustafsson JA, (1997) The novel estrogen receptor-beta subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens. FEBS Lett 410: 87-90.
13. Wen DX, Xu YF, Mais DE, Goldman ME, McDonnell DP, (1994) The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells. Mol Cell Biol 14: 8356-8364.
14. Kastner P, Krust A, Turcotte B, Stropp U, Tora L, et al. (1990) Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J. 9: 1603-1614.
15. Wang H, Critchley HO, Kelly RW, Shen D, Baird DT, (1998) Progesterone receptor subtype B is differentially regulated in human endometrial stroma. Mol Hum Reprod 4: 407-412.
16. Lessey BA, Killam AP, Metzger DA, Haney AF, Greene GL, et al. (1988) Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle. J Clin Endocrinol Metab 67: 334-340.
17. Berrodin TJ, Jelinsky SA, Graciani N, Butera JA, Zhang Z, et al. (2009) Novel progesterone receptor modulators with gene selective and context-dependent partial agonism. Biochem Pharmacol 77: 204-215.
18. Buzdar AU, Hortobagyi GN, (1998) Tamoxifen and toremifene in breast cancer: comparison of safety and efficacy. J Clin Oncol 16: 348-353.
19. Bergman L, Beelen ML, Gallee MP, Hollema H, Benraadt J, et al. (2000) Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen. Lancet 356: 881-887.
20. Cohen I, (2004) Endometrial pathologies associated with postmenopausal tamoxifen treatment. Gynecol Oncol 94: 256-266.
21. Goldberg JR, Plescia MG, Anastasio GD, (1998) Mifepristone (RU 486): current knowledge and future prospects. Arch Fam Med 7: 219-222.
22. Brogden RN, Goa KL, Faulds D, (1993) Mifepristone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 45: 384-409.
23. Croxtall JD, Elder MG, White JO, (1990) Hormonal control of proliferation in the Ishikawa endometrial adenocarcinoma cell line. J Steroid Biochem 35: 665-669.
24. Lessey BA, Ilesanmi AO, Castelbaum AJ, Yuan L, Somkuti SG, et al. (1996) Characterization of the functional progesterone receptor in an endometrial adenocarcinoma cell line (Ishikawa): progesterone-induced expression of the alpha1 integrin. J Steroid Biochem Mol Biol 59: 31-39.
25. Nishida M, Kasahara K, Kaneko M, Iwasaki H, Hayashi K, (1985) [Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors]. Nihon Sanka Fujinka Gakkai Zasshi 37: 1103-1111.
26. Trapnell C, Pachter L, Salzberg SL, (2009) TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25: 1105-1111.
27. Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, et al. (2010) Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 28: 511-515.
28. Flicek P, Aken BL, Beal K, Ballester B, Caccamo M, et al. (2008) Ensembl 2008. Nucleic Acids Res 36: D707-714.
29. Golouh R, Cufer T, Sadikov A, Nussdorfer P, Usher PA, et al. (2008) The prognostic value of Stathmin-1, S100A2, and SYK proteins in ER-positive primary breast cancer patients treated with adjuvant tamoxifen monotherapy: an immunohistochemical study. Breast Cancer Res Treat 110: 317-326.
30. Casneuf T, Van de Peer Y, Huber W, (2007) In situ analysis of cross-hybridisation on microarrays and the inference of expression correlation. BMC Bioinformatics 8: 461.
31. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B, (2008) Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 5: 621-628.
32. O'Brien JS, Kishimoto Y, (1991) Saposin proteins: structure, function, and role in human lysosomal storage disorders. FASEB J 5: 301-308.
33. Zhang X, Bocca S, Franchi A, Anderson S, Kaur M, et al. (2010) Do GnRH analogues directly affect human endometrial epithelial cell gene expression? Mol Hum Reprod 16: 347-360.
34. Grimaldi G, Christian M, Steel JH, Henriet P, Poutanen M, et al. (2011) Down-regulation of the histone methyltransferase EZH2 contributes to the epigenetic programming of decidualizing human endometrial stromal cells. Mol Endocrinol 25: 1892-1903.
35. Aplin JD, Hey NA, Graham RA, (1998) Human endometrial MUC1 carries keratan sulfate: characteristic glycoforms in the luminal epithelium at receptivity. Glycobiology 8: 269-276.
36. Acosta AA, Elberger L, Borghi M, Calamera JC, Chemes H, et al. (2000) Endometrial dating and determination of the window of implantation in healthy fertile women. Fertil Steril 73: 788-798.
37. Horne AW, White JO, Lalani el N, (2002) Adhesion molecules and the normal endometrium. BJOG 109: 610-617.
38. Horne AW, Lalani EN, Margara RA, Ryder TA, Mobberley MA, et al. (2005) The expression pattern of MUC1 glycoforms and other biomarkers of endometrial receptivity in fertile and infertile women. Mol Reprod Dev 72: 216-229.
39. Horne AW, Lalani EN, Margara RA, White JO, (2006) The effects of sex steroid hormones and interleukin-1-beta on MUC1 expression in endometrial epithelial cell lines. Reproduction 131: 733-742.
40. Maruyama T, Yoshimura Y, Sabe H, (1999) Tyrosine phosphorylation and subcellular localization of focal adhesion proteins during in vitro decidualization of human endometrial stromal cells. Endocrinology 140: 5982-5990.
41. Moller B, Rasmussen C, Lindblom B, Olovsson M, (2001) Expression of the angiogenic growth factors VEGF, FGF-2, EGF and their receptors in normal human endometrium during the menstrual cycle. Mol Hum Reprod 7: 65-72.
42. Okada H, Nakajima T, Yoshimura T, Yasuda K, Kanzaki H, (2003) Microarray analysis of genes controlled by progesterone in human endometrial stromal cells in vitro. Gynecol Endocrinol 17: 271-280.
43. Arici A, Engin O, Attar E, Olive DL, (1995) Modulation of leukemia inhibitory factor gene expression and protein biosynthesis in human endometrium. J Clin Endocrinol Metab 80: 1908-1915.
44. Hsieh YY, Lin CS, Sun YL, Chang CC, Tsai HD, et al. (2002) In vivo gene transfer of leukemia inhibitory factor (LIF) into mouse endometrium. J Assist Reprod Genet 19: 79-83.
45. Sugino N, Kashida S, Karube-Harada A, Takiguchi S, Kato H, (2002) Expression of vascular endothelial growth factor (VEGF) and its receptors in human endometrium throughout the menstrual cycle and in early pregnancy. Reproduction 123: 379-387.
46. Lonard DM, Smith CL, (2002) Molecular perspectives on selective estrogen receptor modulators (SERMs): progress in understanding their tissue-specific agonist and antagonist actions. Steroids 67: 15-24.
47. Shang Y, Brown M, (2002) Molecular determinants for the tissue specificity of SERMs. Science 295: 2465-2468.
48. McGonigle KF, Smith DD, Marx HF, Morgan RJ, Vasilev SA, et al. (2006) Uterine effects of tamoxifen: a prospective study. Int J Gynecol Cancer 16: 814-820.
49. Johnson SM, Maleki-Dizaji M, Styles JA, White IN, (2007) Ishikawa cells exhibit differential gene expression profiles in response to oestradiol or 4-hydroxytamoxifen. Endocr Relat Cancer 14: 337-350.
50. Gielen SC, Kuhne LC, Ewing PC, Blok LJ, Burger CW, (2005) Tamoxifen treatment for breast cancer enforces a distinct gene-expression profile on the human endometrium: an exploratory study. Endocr Relat Cancer 12: 1037-1049.
51. Gielen SC, Burger CW, Kuhne LC, Hanifi-Moghaddam P, Blok LJ, (2005) Analysis of estrogen agonism and antagonism of tamoxifen, raloxifene, and ICI182780 in endometrial cancer cells: a putative role for the epidermal growth factor receptor ligand amphiregulin. J Soc Gynecol Investig 12: e55-67.
52. Fu M, Wang C, Li Z, Sakamaki T, Pestell RG, (2004) Minireview: Cyclin D1: normal and abnormal functions. Endocrinology 145: 5439-5447.
53. Cao QJ, Einstein MH, Anderson PS, Runowicz CD, Balan R, et al. (2002) Expression of COX-2, Ki-67, cyclin D1, and P21 in endometrial endometrioid carcinomas. Int J Gynecol Pathol 21: 147-154.
54. Machin P, Catasus L, Pons C, Munoz J, Matias-Guiu X, et al. (2002) CTNNB1 mutations and beta-catenin expression in endometrial carcinomas. Hum Pathol 33: 206-212.
55. Moreno-Bueno G, Rodriguez-Perales S, Sanchez-Estevez C, Hardisson D, Sarrio D, et al. (2003) Cyclin D1 gene (CCND1) mutations in endometrial cancer. Oncogene 22: 6115-6118.
56. Wong YF, Cheung TH, Lo KW, Yim SF, Siu NS, et al. (2007) Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling. Oncogene 26: 1971-1982.
57. Guo F, Li Y, Liu Y, Wang J, Li Y, et al. (2010) Inhibition of metastasis-associated lung adenocarcinoma transcript 1 in CaSki human cervical cancer cells suppresses cell proliferation and invasion. Acta Biochim Biophys Sin (Shanghai) 42: 224-229.
58. Brown AJ, Leibold EA, Munro HN, (1983) Isolation of cDNA clones for the light subunit of rat liver ferritin: evidence that the light subunit is encoded by a multigene family. Proc Natl Acad Sci U S A 80: 1265-1269.
59. Danielsson KG, Swahn ML, Bygdeman M, (1997) The effect of various doses of mifepristone on endometrial leukaemia inhibitory factor expression in the midluteal phase-an immunohistochemical study. Hum Reprod 12: 1293-1297.
60. Lalitkumar PG, Sengupta J, Karande AA, Ghosh D, (1998) Placental protein 14 in endometrium during menstrual cycle and effect of early luteal phase mifepristone administration on its expression in implantation stage endometrium in the rhesus monkey. Hum Reprod 13: 3478-3486.
61. Hapangama DK, Critchley HO, Henderson TA, Baird DT, (2002) Mifepristone-induced vaginal bleeding is associated with increased immunostaining for cyclooxygenase-2 and decrease in prostaglandin dehydrogenase in luteal phase endometrium. J Clin Endocrinol Metab 87: 5229-5234.
62. Danielsson KG, Marions L, Bygdeman M, (2003) Effects of mifepristone on endometrial receptivity. Steroids 68: 1069-1075.
63. Chwalisz K, Brenner RM, Fuhrmann UU, Hess-Stumpp H, Elger W, (2000) Antiproliferative effects of progesterone antagonists and progesterone receptor modulators on the endometrium. Steroids 65: 741-751.
64. Catalano RD, Critchley HO, Heikinheimo O, Baird DT, Hapangama D, et al. (2007) Mifepristone induced progesterone withdrawal reveals novel regulatory pathways in human endometrium. Mol Hum Reprod 13: 641-654.
65. Ghosh D, Sharkey AM, Charnock-Jones DS, Smith SK, Sengupta J, (2009) Effect of low-dose mifepristone administration on day 2 after ovulation on transcript profiles in implantation-stage endometrium of rhesus monkeys. Reproduction 138: 357-370.
66. Sun X, Christow A, Marions L, Gemzell-Danielsson K, (2003) Progesterone receptor isoform B in the human fallopian tube and endometrium following mifepristone. Contraception 67: 319-326.
67. Hodgson MC, Astapova I, Cheng S, Lee LJ, Verhoeven MC, et al. (2005) The androgen receptor recruits nuclear receptor CoRepressor (N-CoR) in the presence of mifepristone via its N and C termini revealing a novel molecular mechanism for androgen receptor antagonists. J Biol Chem 280: 6511-6519.